Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 361801 - 361820 out of 563841 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania (VVKT) | (L04AC05) ustekinumab (adm: P) | STEQEYMA 90 mg injekcinis tirpalas užpildytame švirkšte 1 ml N1 (Celltrion Healthcare Hungary Kft., Vengrija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | CelltrionHealthcareHungaryKft.,Vengrija |
| Lithuania (VVKT) | (L04AC05) ustekinumab (adm: P) | Uzpruvo 90 mg injekcinis tirpalas užpildytame švirkšte 1 ml N1 (STADA Arzneimittel AG, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | STADAArzneimittelAG,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Avtozma 20 mg koncentratas infuziniam tirpalui 4 ml N1 (Celltrion Healthcare Hungary Kft., Vengrija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareHungaryKft.,Vengrija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Tocilizumab STADA [Tofidence] 20 mg/ml koncentratas infuziniam tirpalui 4 ml N1 (STADA Arzneimittel AG, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | STADAArzneimittelAG,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Tocilizumab STADA [Tofidence] 20 mg/ml koncentratas infuziniam tirpalui 4 ml N4 (STADA Arzneimittel AG, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | STADAArzneimittelAG,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml koncentratas infuziniam tirpalui 10 ml N4 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml koncentratas infuziniam tirpalui 20 ml N1 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml koncentratas infuziniam tirpalui 4 ml N4 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml koncentratas infuziniam tirpalui 4 ml, N4 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg injekcinis tirpalas užpildytame švirkštiklyje N4 (Celltrion Healthcare Hungary Kft., Vengrija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareHungaryKft.,Vengrija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | RoActemra 162 mg injekcinis tirpalas užpildytame švirkšte 0,9 ml N4 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg injekcinis tirpalas užpildytame švirkšte N4 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania (VVKT) | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg injekcinis tirpalas užpildytame švirkštiklyje N4 (Fresenius Kabi Deutschland GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH,Vokietija |
| Lithuania (VVKT) | (L04AC10) secukinumab (adm: P) | Cosentyx 150 mg injekcinis tirpalas užpildytame švirkštiklyje N1 (SensoReady) (Novartis Europharm Ltd., Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd.,Airija |
| Lithuania (VVKT) | (L04AC10) secukinumab (adm: P) | Cosentyx 300 mg injekcinis tirpalas užpildytame švirkštiklyje 2 ml N1 (Novartis Europharm Ltd., Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd.,Airija |
| Lithuania (VVKT) | (L04AC13) ixekizumab (adm: P) | Taltz 80 mg injekcinis tirpalas užpildytame švirkštiklyje 1 ml N1 (Eli Lilly and Company (Ireland) Limited, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Axial Spondyloarthritis;Arthritis, Juvenile | EliLillyandCompany[Ireland]Limited,Airija |
| Lithuania (VVKT) | (L04AC16) guselkumab (adm: P) | Tremfya 100 mg injekcinis tirpalas užpildytame švirkštiklyje 1 ml N1 (OnePress) (Janssen-Cilag International N.V., Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania (VVKT) | (L04AC18) risankizumab (adm: P) | Skyrizi 600 mg koncentratas infuziniam tirpalui N1 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Colitis, Ulcerative;Crohn Disease | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
| Lithuania (VVKT) | (L04AC18) risankizumab (adm: P) | Skyrizi 150 mg injekcinis tirpalas užpildytame švirkštiklyje N1 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Colitis, Ulcerative;Crohn Disease | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
| Lithuania (VVKT) | (L04AC18) risankizumab (adm: P) | Skyrizi 180 mg injekcinis tirpalas užtaise 1,2 ml ir ant kūno tvirtinamas injektorius N1 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Colitis, Ulcerative;Crohn Disease | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
Pages
